Mitsubishi UFJ Asset Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-5,038
Closed -$1.12M – 931
2018
Q3
$1.12M Buy
5,038
+2,200
+78% +$446K 0.02% 570
2018
Q2
$455K Buy
2,838
+1,044
+58% +$133K 0.01% 714
2018
Q1
$168K Buy
1,794
+987
+122% +$73.7K ﹤0.01% 758
2017
Q4
$57K Buy
807
+374
+86% +$24.8K ﹤0.01% 812
2017
Q3
$26K Buy
+433
New +$21.5K ﹤0.01% 824

Other funds holding MED

Mitsubishi UFJ Asset Management's MED Position: Q4 2018 in Review

Mitsubishi UFJ Asset Management sold out of Medifast (MED) in Q4 2018, closing a stake of 5,038 shares — an estimated $1.12M sold.

Mitsubishi UFJ Asset Management first reported a position in MED in Q3 2017 and held it in 5 quarters. The position peaked at $1.12M in Q3 2018. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

  • Mitsubishi UFJ Asset Management reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 5,038 Medifast shares in Q4 2018, an estimated $1.12M.
  • Mitsubishi UFJ Asset Management first reported a position in Medifast in Q3 2017 and held it in 5 quarters.
  • Mitsubishi UFJ Asset Management's Medifast position peaked at $1.12M in Q3 2018.
  • 247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.